Evidence map›Paper›PMID 37311756›Full record

ArticleNature communications2023

Directed differentiation of mouse pluripotent stem cells into functional lung-specific mesenchyme.

Andrea B Alber, Hector A Marquez, Liang Ma, George Kwong, Bibek R Thapa, Carlos Villacorta-Martin, Jonathan Lindstrom-Vautrin, Pushpinder Bawa, Feiya Wang, Yongfeng Luo and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Stem cells in organogenesis and regeneration.Stem cell research & therapy · 2026
    Review
  6. The mechanical microenvironment and lung stem cell fate.Frontiers in cell and developmental biology · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Loss of lung mesenchymal identities in culture and a screening approach to identify restorative cues.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  11. Review
  12. Review
  13. From Epithelium to Therapy: Transitional Cells in Lung Fibrosis.American journal of respiratory cell and molecular biology · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Andrea B AlberCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.ORCID 0000-0001-6183-7208
Hector A MarquezCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Liang MaCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
George KwongCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Bibek R ThapaCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Carlos Villacorta-MartinCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Jonathan Lindstrom-VautrinCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Pushpinder BawaCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Feiya WangCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Yongfeng LuoDepartment of Surgery, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90027, USA.
Laertis IkonomouDepartment of Oral Biology, School of Dental Medicine, University at Buffalo, Buffalo, NY, 14260, USA.ORCID 0000-0003-0993-6713
Wei ShiDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.
Darrell N KottonCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA. dkotton@bu.edu.ORCID 0000-0002-9604-8476
Boston University · USJacobs Institute · USUniversity of Cincinnati Medical Center · USUniversity of Southern California · US

Funding

Editing Alveolar Progenitor Cells for Correction of Monogenic DiseaseU01HL134745 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI KOTTON, DARRELL N., MORRISEY, EDWARD E · 2016 to 2022
$8.3M
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damageU01HL134766 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAPMAN, HAROLD A, KOTTON, DARRELL N. · 2016 to 2022
$8.1M
Derivation of Transplantable Lung Epithelial Progenitors from iPS CellsR01HL095993 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton · 2009 to 2026
$7.5M
Pathogenic Mechanisms of Pulmonary LymphangioleiomyomatosisR01HL146541 · NHLBI · UNIVERSITY OF CINCINNATI · PI SHI, WEI · 2019 to 2022
$2.6M
Molecular mechanisms of pulmonary disease in Birt-Hogg-Dube syndromeR01HL141352 · NHLBI · UNIVERSITY OF CINCINNATI · PI SHI, WEI · 2018 to 2021
$2.6M
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCsU01HL152976 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOTTON, DARRELL N. · 2021 to 2024
$2.5M
Gene regulatory networks in early lung epithelial cell fate decisionsR01HL158965 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Laertis Ikonomou · 2023 to 2026
$2.5M
Mechanisms of Cell Death and Inflammation in Chemotherapy-Induced Oral MucositisR56DE028545 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DIAZ, PATRICIA · 2020 to 2020
$657k
Retinoic Acid Regulation of Airway Smooth Muscle Differentiation in the DevelopinF32HL117529 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MARQUEZ, HECTOR ANTONIO · 2013 to 2013
$39k
NHLBI NIH HHS F32 HL117529NHLBI NIH HHS R01 HL095993NHLBI NIH HHS R01 HL141352NHLBI NIH HHS R01 HL146541NHLBI NIH HHS R01 HL158965NHLBI NIH HHS U01 HL134745NHLBI NIH HHS U01 HL134766NHLBI NIH HHS U01 HL152976NIDCR NIH HHS R56 DE028545
6 · The paper itself

Abstract

While the generation of many lineages from pluripotent stem cells has resulted in basic discoveries and clinical trials, the derivation of tissue-specific mesenchyme via directed differentiation has markedly lagged. The derivation of lung-specific mesenchyme is particularly important since this tissue plays crucial roles in lung development and disease. Here we generate a mouse induced pluripotent stem cell (iPSC) line carrying a lung-specific mesenchymal reporter/lineage tracer. We identify the pathways (RA and Shh) necessary to specify lung mesenchyme and find that mouse iPSC-derived lung mesenchyme (iLM) expresses key molecular and functional features of primary developing lung mesenchyme. iLM recombined with engineered lung epithelial progenitors self-organizes into 3D organoids with juxtaposed layers of epithelium and mesenchyme. Co-culture increases yield of lung epithelial progenitors and impacts epithelial and mesenchymal differentiation programs, suggesting functional crosstalk. Our iPSC-derived population thus provides an inexhaustible source of cells for studying lung development, modeling diseases, and developing therapeutics.

Indexed as

Induced Pluripotent Stem CellsPluripotent Stem CellsAnimalsCell DifferentiationMesodermMiceThorax

Identifiers

PMID37311756
PMCPMC10264380
OpenAlexW4380537255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.